These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30081785)

  • 1. Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients.
    Fröhlich E
    Curr Drug Metab; 2019; 20(13):1039-1040. PubMed ID: 30081785
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level.
    Nair SS; Sarasamma S; Gracious N; George J; Anish TS; Radhakrishnan R
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():197-200. PubMed ID: 25894154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient.
    Ma TK; Chow KM; Kwan BC; Leung CB; Szeto CC; Li PK
    Nephrology (Carlton); 2017 Feb; 22(2):184. PubMed ID: 28064453
    [No Abstract]   [Full Text] [Related]  

  • 4. Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients.
    Riva N; Galván ME; Cáceres-Guido P; Dip M; Licciardone N; Imventarza O; Schaiquevich P; Buamscha D
    Int J Clin Pharmacol Ther; 2017 Apr; 55(4):352-354. PubMed ID: 28079516
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients.
    Kagaya H; Niioka T; Saito M; Inoue T; Numakura K; Yamamoto R; Akamine Y; Habuchi T; Satoh S; Miura M
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29547545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
    Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
    Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial.
    Arns W; Huppertz A; Rath T; Ziefle S; Rump LC; Hansen A; Budde K; Lehner LJ; Shipkova M; Baeumer D; Kroeger I; Sieder C; Klein T; Schenker P
    Transplantation; 2017 Nov; 101(11):2780-2788. PubMed ID: 28658202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting High Calcineurin Inhibitor Levels After Acute Rejection With Less Tremor: A New Strategy.
    Alhamad T; Venkatachalam K; Daloul R; Brennan DC; Malone AF
    Transplantation; 2017 Aug; 101(8):e287-e288. PubMed ID: 28422926
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of Genetic Polymorphism in CYP3A4 and CYP3A5 Genes on Tacrolimus Dose Among Kidney Transplant Recipients.
    Yousef AM; Qosa H; Bulatova N; Abuhaliema A; Almadhoun H; Khayyat G; Olemat M
    Iran J Kidney Dis; 2016 May; 10(3):156-63. PubMed ID: 27225724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary study searching for the right dose of tacrolimus in very young (≤4 years) renal transplant patients.
    Martial LC; Verstegen RH; Cornelissen EA; Aarnoutse RE; Schreuder MF; Brüggemann RJ
    J Pharm Pharmacol; 2016 Nov; 68(11):1366-1372. PubMed ID: 27669677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CYP3A5 and ABCB1 Gene Polymorphisms on Tacrolimus Blood Concentration in Renal Transplant Recipients.
    Yildirim E; Şahin G; Kaltuş Z; Çolak E
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.
    Sanghavi K; Brundage RC; Miller MB; Schladt DP; Israni AK; Guan W; Oetting WS; Mannon RB; Remmel RP; Matas AJ; Jacobson PA
    Pharmacogenomics J; 2017 Jan; 17(1):61-68. PubMed ID: 26667830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower tacrolimus trough levels in the late period after living donor liver transplantation contribute to improvements in long-term clinical outcomes.
    Geng L; Wang LD; Huang JJ; Shen T; Wang ZY; Lin BY; Ye YF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):204-209. PubMed ID: 29807766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding.
    van der Schaft J; van Schaik RH; van Zuilen AD; Hijnen DJ; Berg MT; van den Broek MP; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    J Dermatol Sci; 2016 Jan; 81(1):66-8. PubMed ID: 26547110
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative analysis for optimizing the modified release tacrolimus (Advagraf) after kidney transplantation: A prospective randomized trial.
    Bakr MA; Nagib AM; Donia AF; Denewar AA; Abu-Elmagd MM; Abbas MH; Abdel-Rahman AM; Mashaly ME; Elsaftawy MM; Ghoneim MA
    Saudi J Kidney Dis Transpl; 2018; 29(6):1267-1273. PubMed ID: 30588956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation.
    David-Neto E; Romano P; Kamada Triboni AH; Ramos F; Agena F; Almeida Rezende Ebner P; Altona M; Galante NZ; Brambate Carvalhinho Lemos F
    Transplantation; 2017 Jun; 101(6):1365-1372. PubMed ID: 27482958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMET
    Choi Y; Jiang F; An H; Park HJ; Choi JH; Lee H
    Pharmacogenomics J; 2017 Mar; 17(2):174-179. PubMed ID: 26882121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus-Induced Diabetic Ketoacidosis After Allogeneic Bone Marrow Transplant.
    Solmaz S; Gökgöz Z; Gereklioğlu Ç; Yeral M; Boğa C; Özdoğu H
    Exp Clin Transplant; 2017 Dec; 15(6):702-703. PubMed ID: 26643544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual administration of tacrolimus: current trends and available evidence.
    Doligalski CT; Liu EC; Sammons CM; Silverman A; Logan AT
    Pharmacotherapy; 2014 Nov; 34(11):1209-19. PubMed ID: 25251980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime.
    Whalen HR; Glen JA; Harkins V; Stevens KK; Jardine AG; Geddes CC; Clancy MJ
    Transplantation; 2017 Feb; 101(2):430-436. PubMed ID: 26950724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.